Dimensional Fund Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.2M Buy
1,695,568
+621,929
+58% +$5.25M ﹤0.01% 2110
2026
Q2
$8.5M Buy
+1,073,639
New +$6.86M ﹤0.01% 2374
2024
Q3
– Sell
-48,663
Closed -$109K – 3396
2024
Q2
$109K Sell
48,663
-6,437
-12% -$13K ﹤0.01% 3241
2024
Q1
$122K Buy
+55,100
New +$143K ﹤0.01% 3241
2022
Q3
– Sell
-45,082
Closed -$69K – 3532
2022
Q2
$69K Buy
45,082
+5,688
+14% +$12K ﹤0.01% 3369
2022
Q1
$101K Sell
39,394
-30,478
-44% -$74.5K ﹤0.01% 3393
2021
Q4
$204K Buy
69,872
+21,402
+44% +$46.2K ﹤0.01% 3338
2021
Q3
$119K Sell
48,470
-31,717
-40% -$92.1K ﹤0.01% 3410
2021
Q2
$326K Buy
+80,187
New +$306K ﹤0.01% 3247

Other funds holding XERS

Dimensional Fund Advisors's XERS Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Xeris Biopharma Holdings (XERS) stake by 58% in Q3 2026, buying an estimated $5.25M and bringing the position to 1,695,568 shares worth $16.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Dimensional Fund Advisors first reported a position in XERS in Q2 2021 and has held it in 9 quarters since. 246 funds tracked by Wall St. Rank hold XERS as of Q3 2026.

  • Dimensional Fund Advisors held 1,695,568 shares of Xeris Biopharma Holdings worth $16.2M as of Q3 2026.
  • Dimensional Fund Advisors bought 621,929 Xeris Biopharma Holdings shares in Q3 2026, an estimated $5.25M.
  • Xeris Biopharma Holdings made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2110 holding.
  • Dimensional Fund Advisors first reported a position in Xeris Biopharma Holdings in Q2 2021 and has held it in 9 quarters since.
  • 246 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.